Johnson & Johnson (JNJ) 99.62 $JNJ
Tracking Tweedy Browne's Portfolio - Q4 2014 Update
John Vincent - at Seeking Alpha - 21 mins ago
KOF: 84.71 (+0.59), DNOW: 25.64 (+0.70), CNQ: 31.63 (+0.45), WMT: 85.81 (-0.08), GOOG: 549.01 (+6.08), DEO: 113.89 (-1.40), BSBR: 5.07 (+0.19), NOV: 53.36 (+0.80), FII: 35.09 (+0.20), CSCO: 29.43 (-0.03), MA: 87.14 (-0.38), PSX: 76.62 (+1.51), TMK: 54.05 (+0.35), UN: 42.28 (-0.30), HAL: 44.19 (+1.42), AGCO: 49.78 (+0.97), COP: 69.88 (+1.84), WFC: 55.33 (+0.47), GSK: 47.94 (+1.99), UL: 43.03 (-0.17), CTWS: 37.37 (-0.03), NWLI: 245.15 (+0.45), RDS.A: 66.32 (+0.97), ANAT: 104.90 (-0.10), BRK.B: 148.34 (-1.45), BRK.A: 222,555.00 (-1,905.00), NVS: 102.20 (-0.17), MMM: 165.94 (+0.03), LMT: 196.95 (-0.53), UNF: 121.82 (-0.50), XOM: 93.37 (+1.00), SHEN: 30.36 (+0.37), JNJ: 99.62 (+1.18), GOOGL: 551.16 (+5.15), BK: 39.20 (-0.21), UNP: 122.60 (-1.23), JOY: 44.14 (+0.35), DVN: 66.47 (+0.69), AXP: 78.08 (-2.40), EMR: 58.68 (+0.08), HSBC: 46.13 (-0.01), ITW: 98.26 (+0.48), PM: 82.87 (-0.82), BRO: 33.01 (+0.20), TOT: 54.14 (-0.36), USB: 45.07 (-0.05), BAX: 70.39 (+0.31), CMCSA: 59.47 (+1.09), VZ: 49.31 (-0.21)
3 Stocks That Were Huge Winners Last Week
Todd Campbell, The Motley Fool - Motley Fool - 24 mins ago
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. The market's best-performing companies last week included...
JNJ: 99.62 (+1.18), BIIB: 391.66 (-0.45), PTLA: 34.96 (+3.13), SHPG: 239.82 (+6.11), PFE: 34.64 (-0.23), SGMO: 15.40 (+0.14), BMY: 60.04 (+0.56), MOH: 59.66 (+0.26)
2 Small Biotech Stocks Dreaming Big in Hepatitis C
Todd Campbell and Michael Douglass, The Motley Fool - Motley Fool - 1 hr 50 mins ago
Hepatitis C treatment has progressed by leaps and bounds in the past few years, and appears to be accelerating even more quickly now. Cure rates have increased, treatment times are plummeting, and side effects are falling away. Is now the time to...
JNJ: 99.62 (+1.18), VRTX: 113.66 (+4.03), ISIS: 63.86 (-0.43), ALNY: 95.54 (+1.67), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), SHPG: 239.82 (+6.11), MRK: 58.81 (-0.07), CVS: 102.63 (-0.37), ABBV: 58.05 (+1.00), RGLS: 16.85 (-0.13)
Stay Calm And All Will Be Well
George Acs - at Seeking Alpha - 2 hrs 24 mins ago
KO: 41.99 (-0.18), JNJ: 99.62 (+1.18), GE: 25.15 (+0.26), AXP: 78.08 (-2.40), FB: 75.74 (-0.49), COST: 147.10 (-0.66), TWTR: 48.50 (+0.55), INTC: 34.36 (+0.23), UAL: 66.23 (-1.11), K: 63.20 (-0.10)
Is This Company the Big Winner in Obama's Push for Precision Medicine?
Todd Campbell, The Motley Fool - Motley Fool - 2 hrs 57 mins ago
Source: Illumina Inc. President Obama has released more details about his plans to fund a precision medicine initiative that the administration hopes will mean that doctors can deliver the right medicine to the right patient at the right dose ...
JNJ: 99.62 (+1.18), BMRN: 100.76 (+1.98), AZN: 69.96 (+0.20), ILMN: 198.54 (+1.81), BMY: 60.04 (+0.56), SNY: 49.42 (+0.82)
Coherus BioSciences: A Sharp Increase, A Sharp Drop, Plus Collateral News Creates A Buying Opportunity
Regarded Solutions - at Seeking Alpha - Sat Feb 14, 8:50AM CST
JNJ: 99.62 (+1.18), BAX: 70.39 (+0.31), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), HSP: 87.35 (unch), CHRS: 27.11 (-0.71)
Kroger: A Recent Tale Of Dividend Hors D'oeuvres
Eli Inkrot - at Seeking Alpha - Fri Feb 13, 5:29PM CST
JNJ: 99.62 (+1.18), RDS.B: 69.26 (+0.86), KR: 72.86 (+0.41), BP: 41.93 (+0.59), PG: 85.90 (-0.13)
Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 13, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
VRX: 167.00 (-0.50), ACT: 285.37 (+3.71), MDT: 75.26 (+0.33), XON: 39.30 (+1.05), CTIC: 2.23 (-0.02), PFNX: 12.45 (+0.29), JNJ: 99.62 (+1.18), ANTM: 141.05 (-0.95), NVAX: 8.80 (+0.40), SHPG: 239.82 (+6.11), ABBV: 58.05 (+1.00), TBPH: 18.51 (+0.28), SNY: 49.42 (+0.82), ALQA: 6.14 (+0.09), REGN: 402.40 (+0.66), ONCY: 0.51 (+0.02), PFE: 34.64 (-0.23), SLXP: 152.35 (+3.17), EPRS: 7.67 (+0.67), AMGN: 153.48 (+0.30), NKTR: 13.54 (-0.14), ZTS: 45.46 (-0.33), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), GERN: 3.03 (unch)
Jim Cramer's Stop Trading: Apache Has Room to Rise, J&J Takes It on the Chin
at The Street - Fri Feb 13, 12:19PM CST
Jim Cramer says independent energy company Apache is one to watch on great production, growth and a Merrill Lynch upgrade.
JNJ: 99.62 (+1.18), PXD: 157.85 (+9.71), APA: 67.05 (+2.47), GSK: 47.94 (+1.99), CELG: 115.88 (+0.16)
Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Higher
at The Street - Fri Feb 13, 12:00PM CST
The Dow component leading the way higher looks to be Johnson & Johnson (NYSE:JNJ), which is sporting a 76-cent gain (+0.8%) bringing the stock to $99.20.
JNJ: 99.62 (+1.18)
I Am Buying The Pullback In Johnson & Johnson For Yield And Break-Up Potential
Hawkinvest - at Seeking Alpha - Fri Feb 13, 10:58AM CST
JNJ: 99.62 (+1.18)
3 ETFs to Keep You Invested After Retirement
Motley Fool Staff - Motley Fool - Fri Feb 13, 9:10AM CST
Once you retire, your investment priorities shift. You are no longer as focused on growing your nest egg as you are on preserving your wealth and generating income. Many of the investments that work best in a portfolio prior to retirement don't...
VT: 62.05 (+0.39), VTIP: 48.41 (-0.03), TIP: 112.66 (-0.23), JNJ: 99.62 (+1.18), XOM: 93.37 (+1.00), VIG: 82.39 (+0.48), WFC: 55.33 (+0.47), TM: 132.49 (+0.67), AAPL: 127.08 (+0.62)
1 Sentence That Tells You Everything You Need to Know About Each of These 10 Big Pharma Earnings Rep
Sean Williams, The Motley Fool - Motley Fool - Fri Feb 13, 7:02AM CST
Source: AstraZeneca. Earnings season is more than halfway over, and it hasn't been easy to keep pace with hundreds upon hundreds of earnings reports, sometimes all hitting within the same day. Much of the healthcare sector, especially big...
BIIB: 391.66 (-0.45), JNJ: 99.62 (+1.18), GILD: 101.90 (+1.10), MRK: 58.81 (-0.07), AZN: 69.96 (+0.20), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), BMY: 60.04 (+0.56), GSK: 47.94 (+1.99), CELG: 115.88 (+0.16)
Market Maker Surveillance Report. KO, TLM, JNJ, VXX, TVIX, FOXA, Highest Net Sell Volume and Negative Price Friction For Thursday, February 12th 2015
M2 - Fri Feb 13, 2:55AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 4992 companies with "abnormal" market making, 4729 companies with positive Friction Factors and 1825 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Thursday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. The Coca-Cola Co (NYSE:KO), Talisman Energy Inc (NYSE:TLM), Johnson & Johnson (NYSE:JNJ), IPATH S&P 500 VIX S/T FU ETN (NYSE:VXX), VELOCITYSHARES 2X VIX SH-TRM (NYSE:TVIX), (NASDAQ:FOXA). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
KO: 41.99 (-0.18), JNJ: 99.62 (+1.18), TVIX: 2.57 (-0.05), TLM: 7.63 (-0.03), VXX: 30.97 (-0.38), FOXA: 34.72 (+0.31)
Motion to Dismiss Conspiracy Claims Rejected in Lawsuit Over Increased Ovarian Risk from Powder Containing Talc, Parker Waichman Comments
PRWeb - Thu Feb 12, 4:55PM CST
Parker Waichman LLP, a national law firm dedicated to protecting the rights of consumers affected by defective products, is commenting that, United States District Judge Ronnie L. White of the Eastern District of Missouri (St. Louis), denied a Motion to Dismiss Conspiracy Claims brought against Johnson & Johnson and Imerys Talc America, Inc., fka Luzenac America, Inc., over allegations that their talcum powder products led to a woman's death from ovarian cancer. The lawsuit, brought by the woman's husband, is Michael Blaes v. Johnson & Johnson, et al., in the United States District Court, Eastern District of Missouri, Eastern Division, Case Number 4:2014cv00213.
JNJ: 99.62 (+1.18)
Johnson & Johnson Announces Patent and Trademark Office Action Related to REMICADE®
PR Newswire - Thu Feb 12, 1:34PM CST
Johnson & Johnson (NYSE: JNJ) today announced receipt of a further action from the Patent and Trademark Office regarding the re-examination of U.S. Patent No. 6,284,471 ('471) relating to REMICADE® issuing a final rejection of the patent.
JNJ: 99.62 (+1.18)
Novavax starts early stage Ebola vaccine trial
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 12:18PM CST
JNJ: 99.62 (+1.18), NVAX: 8.80 (+0.40), MRK: 58.81 (-0.07), NLNK: 38.84 (+1.51), GSK: 47.94 (+1.99)
Biosimilar firms up on Remicade patent rejection
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 11:56AM CST
JNJ: 99.62 (+1.18), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), EPRS: 7.67 (+0.67), PFNX: 12.45 (+0.29), HSP: 87.35 (unch), NVS: 102.20 (-0.17), CHRS: 27.11 (-0.71)
5 Things GlaxoSmithKline PLC's Management Wants You to Know
Sean Williams, The Motley Fool - Motley Fool - Thu Feb 12, 9:02AM CST
Source: GlaxoSmithKline, Facebook. The fourth quarter was another rough one for U.K.-based pharmaceutical giant GlaxoSmithKline . During the quarter, GlaxoSmithKline saw its revenue tumble 10% to $9.41 billion , inclusive of negative foreign...
JNJ: 99.62 (+1.18), THRX: 14.85 (+1.00), GSK: 47.94 (+1.99), NVS: 102.20 (-0.17)
Greece Issue Is Blown Out Of Proportion - Cramer's Mad Money (2/11/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Feb 12, 6:44AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Wednesday, February 11. It is the overseas issue again. Cramer thinks the critics have come back to cause investor fear on the Germany-Greece showdown. Cramer called it...
PBR.A: 7.13 (+0.48), SDRL: 12.32 (-0.70), GOOG: 549.01 (+6.08), SLB: 88.38 (+2.42), PEP: 99.13 (-1.14), RAD: 8.34 (+0.25), ZTS: 45.46 (-0.33), JNJ: 99.62 (+1.18), CMG: 674.89 (+4.60), DNB: 133.27 (+0.46), AAL: 48.39 (+0.51), GM: 37.62 (-0.40), GOOGL: 551.16 (+5.15), MSFT: 43.87 (+0.78), DOW: 49.44 (+0.29), HSIC: 143.18 (+0.72), AAPL: 127.08 (+0.62), CSCO: 29.43 (-0.03)
Tracking Tweedy Browne's Portfolio - Q4 2014 Update
John Vincent - at Seeking Alpha - 21 mins ago
KOF: 84.71 (+0.59), DNOW: 25.64 (+0.70), CNQ: 31.63 (+0.45), WMT: 85.81 (-0.08), GOOG: 549.01 (+6.08), DEO: 113.89 (-1.40), BSBR: 5.07 (+0.19), NOV: 53.36 (+0.80), FII: 35.09 (+0.20), CSCO: 29.43 (-0.03), MA: 87.14 (-0.38), PSX: 76.62 (+1.51), TMK: 54.05 (+0.35), UN: 42.28 (-0.30), HAL: 44.19 (+1.42), AGCO: 49.78 (+0.97), COP: 69.88 (+1.84), WFC: 55.33 (+0.47), GSK: 47.94 (+1.99), UL: 43.03 (-0.17), CTWS: 37.37 (-0.03), NWLI: 245.15 (+0.45), RDS.A: 66.32 (+0.97), ANAT: 104.90 (-0.10), BRK.B: 148.34 (-1.45), BRK.A: 222,555.00 (-1,905.00), NVS: 102.20 (-0.17), MMM: 165.94 (+0.03), LMT: 196.95 (-0.53), UNF: 121.82 (-0.50), XOM: 93.37 (+1.00), SHEN: 30.36 (+0.37), JNJ: 99.62 (+1.18), GOOGL: 551.16 (+5.15), BK: 39.20 (-0.21), UNP: 122.60 (-1.23), JOY: 44.14 (+0.35), DVN: 66.47 (+0.69), AXP: 78.08 (-2.40), EMR: 58.68 (+0.08), HSBC: 46.13 (-0.01), ITW: 98.26 (+0.48), PM: 82.87 (-0.82), BRO: 33.01 (+0.20), TOT: 54.14 (-0.36), USB: 45.07 (-0.05), BAX: 70.39 (+0.31), CMCSA: 59.47 (+1.09), VZ: 49.31 (-0.21)
3 Stocks That Were Huge Winners Last Week
Todd Campbell, The Motley Fool - Motley Fool - 24 mins ago
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. The market's best-performing companies last week included...
JNJ: 99.62 (+1.18), BIIB: 391.66 (-0.45), PTLA: 34.96 (+3.13), SHPG: 239.82 (+6.11), PFE: 34.64 (-0.23), SGMO: 15.40 (+0.14), BMY: 60.04 (+0.56), MOH: 59.66 (+0.26)
2 Small Biotech Stocks Dreaming Big in Hepatitis C
Todd Campbell and Michael Douglass, The Motley Fool - Motley Fool - 1 hr 50 mins ago
Hepatitis C treatment has progressed by leaps and bounds in the past few years, and appears to be accelerating even more quickly now. Cure rates have increased, treatment times are plummeting, and side effects are falling away. Is now the time to...
JNJ: 99.62 (+1.18), VRTX: 113.66 (+4.03), ISIS: 63.86 (-0.43), ALNY: 95.54 (+1.67), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), SHPG: 239.82 (+6.11), MRK: 58.81 (-0.07), CVS: 102.63 (-0.37), ABBV: 58.05 (+1.00), RGLS: 16.85 (-0.13)
Stay Calm And All Will Be Well
George Acs - at Seeking Alpha - 2 hrs 24 mins ago
KO: 41.99 (-0.18), JNJ: 99.62 (+1.18), GE: 25.15 (+0.26), AXP: 78.08 (-2.40), FB: 75.74 (-0.49), COST: 147.10 (-0.66), TWTR: 48.50 (+0.55), INTC: 34.36 (+0.23), UAL: 66.23 (-1.11), K: 63.20 (-0.10)
Is This Company the Big Winner in Obama's Push for Precision Medicine?
Todd Campbell, The Motley Fool - Motley Fool - 2 hrs 57 mins ago
Source: Illumina Inc. President Obama has released more details about his plans to fund a precision medicine initiative that the administration hopes will mean that doctors can deliver the right medicine to the right patient at the right dose ...
JNJ: 99.62 (+1.18), BMRN: 100.76 (+1.98), AZN: 69.96 (+0.20), ILMN: 198.54 (+1.81), BMY: 60.04 (+0.56), SNY: 49.42 (+0.82)
Coherus BioSciences: A Sharp Increase, A Sharp Drop, Plus Collateral News Creates A Buying Opportunity
Regarded Solutions - at Seeking Alpha - Sat Feb 14, 8:50AM CST
JNJ: 99.62 (+1.18), BAX: 70.39 (+0.31), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), HSP: 87.35 (unch), CHRS: 27.11 (-0.71)
Kroger: A Recent Tale Of Dividend Hors D'oeuvres
Eli Inkrot - at Seeking Alpha - Fri Feb 13, 5:29PM CST
JNJ: 99.62 (+1.18), RDS.B: 69.26 (+0.86), KR: 72.86 (+0.41), BP: 41.93 (+0.59), PG: 85.90 (-0.13)
Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 13, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
VRX: 167.00 (-0.50), ACT: 285.37 (+3.71), MDT: 75.26 (+0.33), XON: 39.30 (+1.05), CTIC: 2.23 (-0.02), PFNX: 12.45 (+0.29), JNJ: 99.62 (+1.18), ANTM: 141.05 (-0.95), NVAX: 8.80 (+0.40), SHPG: 239.82 (+6.11), ABBV: 58.05 (+1.00), TBPH: 18.51 (+0.28), SNY: 49.42 (+0.82), ALQA: 6.14 (+0.09), REGN: 402.40 (+0.66), ONCY: 0.51 (+0.02), PFE: 34.64 (-0.23), SLXP: 152.35 (+3.17), EPRS: 7.67 (+0.67), AMGN: 153.48 (+0.30), NKTR: 13.54 (-0.14), ZTS: 45.46 (-0.33), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), GERN: 3.03 (unch)
Jim Cramer's Stop Trading: Apache Has Room to Rise, J&J Takes It on the Chin
at The Street - Fri Feb 13, 12:19PM CST
Jim Cramer says independent energy company Apache is one to watch on great production, growth and a Merrill Lynch upgrade.
JNJ: 99.62 (+1.18), PXD: 157.85 (+9.71), APA: 67.05 (+2.47), GSK: 47.94 (+1.99), CELG: 115.88 (+0.16)
Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Higher
at The Street - Fri Feb 13, 12:00PM CST
The Dow component leading the way higher looks to be Johnson & Johnson (NYSE:JNJ), which is sporting a 76-cent gain (+0.8%) bringing the stock to $99.20.
JNJ: 99.62 (+1.18)
I Am Buying The Pullback In Johnson & Johnson For Yield And Break-Up Potential
Hawkinvest - at Seeking Alpha - Fri Feb 13, 10:58AM CST
JNJ: 99.62 (+1.18)
3 ETFs to Keep You Invested After Retirement
Motley Fool Staff - Motley Fool - Fri Feb 13, 9:10AM CST
Once you retire, your investment priorities shift. You are no longer as focused on growing your nest egg as you are on preserving your wealth and generating income. Many of the investments that work best in a portfolio prior to retirement don't...
VT: 62.05 (+0.39), VTIP: 48.41 (-0.03), TIP: 112.66 (-0.23), JNJ: 99.62 (+1.18), XOM: 93.37 (+1.00), VIG: 82.39 (+0.48), WFC: 55.33 (+0.47), TM: 132.49 (+0.67), AAPL: 127.08 (+0.62)
1 Sentence That Tells You Everything You Need to Know About Each of These 10 Big Pharma Earnings Rep
Sean Williams, The Motley Fool - Motley Fool - Fri Feb 13, 7:02AM CST
Source: AstraZeneca. Earnings season is more than halfway over, and it hasn't been easy to keep pace with hundreds upon hundreds of earnings reports, sometimes all hitting within the same day. Much of the healthcare sector, especially big...
BIIB: 391.66 (-0.45), JNJ: 99.62 (+1.18), GILD: 101.90 (+1.10), MRK: 58.81 (-0.07), AZN: 69.96 (+0.20), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), BMY: 60.04 (+0.56), GSK: 47.94 (+1.99), CELG: 115.88 (+0.16)
Market Maker Surveillance Report. KO, TLM, JNJ, VXX, TVIX, FOXA, Highest Net Sell Volume and Negative Price Friction For Thursday, February 12th 2015
M2 - Fri Feb 13, 2:55AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 4992 companies with "abnormal" market making, 4729 companies with positive Friction Factors and 1825 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Thursday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. The Coca-Cola Co (NYSE:KO), Talisman Energy Inc (NYSE:TLM), Johnson & Johnson (NYSE:JNJ), IPATH S&P 500 VIX S/T FU ETN (NYSE:VXX), VELOCITYSHARES 2X VIX SH-TRM (NYSE:TVIX), (NASDAQ:FOXA). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
KO: 41.99 (-0.18), JNJ: 99.62 (+1.18), TVIX: 2.57 (-0.05), TLM: 7.63 (-0.03), VXX: 30.97 (-0.38), FOXA: 34.72 (+0.31)
Motion to Dismiss Conspiracy Claims Rejected in Lawsuit Over Increased Ovarian Risk from Powder Containing Talc, Parker Waichman Comments
PRWeb - Thu Feb 12, 4:55PM CST
Parker Waichman LLP, a national law firm dedicated to protecting the rights of consumers affected by defective products, is commenting that, United States District Judge Ronnie L. White of the Eastern District of Missouri (St. Louis), denied a Motion to Dismiss Conspiracy Claims brought against Johnson & Johnson and Imerys Talc America, Inc., fka Luzenac America, Inc., over allegations that their talcum powder products led to a woman's death from ovarian cancer. The lawsuit, brought by the woman's husband, is Michael Blaes v. Johnson & Johnson, et al., in the United States District Court, Eastern District of Missouri, Eastern Division, Case Number 4:2014cv00213.
JNJ: 99.62 (+1.18)
Johnson & Johnson Announces Patent and Trademark Office Action Related to REMICADE®
PR Newswire - Thu Feb 12, 1:34PM CST
Johnson & Johnson (NYSE: JNJ) today announced receipt of a further action from the Patent and Trademark Office regarding the re-examination of U.S. Patent No. 6,284,471 ('471) relating to REMICADE® issuing a final rejection of the patent.
JNJ: 99.62 (+1.18)
Novavax starts early stage Ebola vaccine trial
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 12:18PM CST
JNJ: 99.62 (+1.18), NVAX: 8.80 (+0.40), MRK: 58.81 (-0.07), NLNK: 38.84 (+1.51), GSK: 47.94 (+1.99)
Biosimilar firms up on Remicade patent rejection
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 11:56AM CST
JNJ: 99.62 (+1.18), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), EPRS: 7.67 (+0.67), PFNX: 12.45 (+0.29), HSP: 87.35 (unch), NVS: 102.20 (-0.17), CHRS: 27.11 (-0.71)
5 Things GlaxoSmithKline PLC's Management Wants You to Know
Sean Williams, The Motley Fool - Motley Fool - Thu Feb 12, 9:02AM CST
Source: GlaxoSmithKline, Facebook. The fourth quarter was another rough one for U.K.-based pharmaceutical giant GlaxoSmithKline . During the quarter, GlaxoSmithKline saw its revenue tumble 10% to $9.41 billion , inclusive of negative foreign...
JNJ: 99.62 (+1.18), THRX: 14.85 (+1.00), GSK: 47.94 (+1.99), NVS: 102.20 (-0.17)
Greece Issue Is Blown Out Of Proportion - Cramer's Mad Money (2/11/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Feb 12, 6:44AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Wednesday, February 11. It is the overseas issue again. Cramer thinks the critics have come back to cause investor fear on the Germany-Greece showdown. Cramer called it...
PBR.A: 7.13 (+0.48), SDRL: 12.32 (-0.70), GOOG: 549.01 (+6.08), SLB: 88.38 (+2.42), PEP: 99.13 (-1.14), RAD: 8.34 (+0.25), ZTS: 45.46 (-0.33), JNJ: 99.62 (+1.18), CMG: 674.89 (+4.60), DNB: 133.27 (+0.46), AAL: 48.39 (+0.51), GM: 37.62 (-0.40), GOOGL: 551.16 (+5.15), MSFT: 43.87 (+0.78), DOW: 49.44 (+0.29), HSIC: 143.18 (+0.72), AAPL: 127.08 (+0.62), CSCO: 29.43 (-0.03)
